Statement of Organization, Functions, and Delegations of Authority, 25578 [05-9539]
Download as PDF
<![CDATA[
25578
Federal Register / Vol. 70, No. 92 / Friday, May 13, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76), dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 69 FR 77756, dated
December 28, 2004) is amended to
reflect the establishment of the Office of
the Chief Science Officer.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
functional statement for the Office of
Science Policy and Technology Transfer
(CAE) and insert the following:
Office of the Chief Science Officer
(CAS). The Chief Science Officer and
staff provide CDC/ATSDR with
scientific vision and leadership in
science innovation, research, ethics, and
science administration. Activities in
support of the mission include: (1)
Ensures stability and commitment to
long-term scientific investments as the
basis for achieving CDC’s two
overarching health protection goals; (2)
provides coordination for the agency’s
public health research program, both for
intramural and extramural research
activities; (3) upholds scientific ideals,
establishes an environment thriving
with scientific excellence, innovation,
integrity, learning and discovery, and
timely dissemination and translation
into practice of scientific information,
innovations, and technology with the
ultimate goal of improving public
health; (4) facilitates developing
strategic and trans-disciplinary
approaches for long-term planning and
evaluation of CDC’s scientific enterprise
and ensuring sustainability of CDC’s
scientific output, establishing and
sustaining high-level national and
global alliances and synergy, and a
coordinated approach to providing
scientific foundation for development of
public health policies; (5) advises the
CDC Director and Senior Staff on
science matters and represents CDC in
these areas to the Department, other
agencies, and Congress; (6) develops
and disseminates scientific policies for
CDC/ATSDR; (7) maintains the integrity
and productivity of CDC’s scientists by
resolving controversial scientific issues,
VerDate jul<14>2003
15:59 May 12, 2005
Jkt 205001
supporting trailing and information
exchange, and providing direction on
matters of scientific integrity; (8) assures
the protection of human subjects in
public health research and participates
in national and international initiatives
in public health protection; (9) manages
CDC’s intellectual property (e.g.,
patents, trademarks, copyrights) and
promotes the transfer of new technology
from CDC research to the private sector
to facilitate and enhance the
development of diagnostic products,
vaccines, and products to improve
occupational safety; (10) manages the
confidentiality function for sensitive
research data; (11) facilitates the agency
response to the Privacy Act, the
Paperwork Reduction Act, HIPAA, and
FERPA.
Revise the functional statement for
the Management Analysis and Services
Office (CAJ6), Office of the Chief
Operating Officer (CAJ), by deleting
item (1) and inserting the following: (1)
Plans, coordinates, and provides CDCwide management and information
services in the following areas: policy
development and consultation, studies
and surveys, delegations of authorities,
organizations and functions, records
management, printing procurement and
reproduction, and meeting management,
forms design and management,
publications distribution, mail services,
public inquiries, information quality,
and Federal advisory committee
management.
Delete the items (7) and (8) of the
functional statement for the
Management Analysis and Policy
Branch (CAJ64) and renumber the
remaining items accordingly.
Dated: April 28, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 05–9539 Filed 5–12–05; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10130]
Emergency Clearance: Public
Information Collection Requirements
Submitted to the Office of Management
and Budget (OMB)
Center for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
AGENCY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, submitted the
following collection for emergency
review and approval.
We requested an emergency review
because the collection of this
information is needed before the
expiration of the normal time limits
under OMB’s regulations at 5 CFR part
1320. This is necessary to ensure
compliance with provisions of Section
1011 of the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA). We cannot reasonably
comply with the normal clearance
procedures because of the effective
implementation date associated with
this provision of MMA.
OMB evaluated the collection for
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
the accuracy of the estimated burden;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
OMB approved the emergency review
of the information collection referenced
below on May 9, 2005. OMB approved
CMS’’ request for the information
collection titled, ‘‘Federal Funding of
Emergency Health Services (Section
1011): Provider Payment Determination
and Request for Section 1011 Hospital
On-Call Payments to Physicians’’
(OMB#:0938–NEW) for a 180-day
approval period.
Background
Section 1011 provides $250 million
per year for fiscal years (FY) 2005–2008
for payments to eligible providers for
emergency health services provided to
undocumented aliens and other
specified aliens. Two-thirds of the funds
will be divided among all 50 states and
the District of Columbia based on their
relative percentages of undocumented
aliens. One-third will be divided among
the six states with the largest number of
undocumented alien apprehensions.
From the respective state allotments,
payments will be made directly to
hospitals, certain physicians, and
ambulance providers for some or all of
the costs of providing emergency health
care required under section 1867 and
related hospital inpatient, outpatient
and ambulance services to eligible
individuals. Eligible providers may
include an Indian Health Service facility
whether operated by the Indian Health
Service or by an Indian tribe or tribal
organization. A Medicare critical access
hospital (CAH) is also a hospital under
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 70, Number 92 (Friday, May 13, 2005)]
[Notices]
[Page 25578]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9539]
[[Page 25578]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76), dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 69 FR 77756, dated December 28, 2004) is
amended to reflect the establishment of the Office of the Chief Science
Officer.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and functional statement for the
Office of Science Policy and Technology Transfer (CAE) and insert the
following:
Office of the Chief Science Officer (CAS). The Chief Science
Officer and staff provide CDC/ATSDR with scientific vision and
leadership in science innovation, research, ethics, and science
administration. Activities in support of the mission include: (1)
Ensures stability and commitment to long-term scientific investments as
the basis for achieving CDC's two overarching health protection goals;
(2) provides coordination for the agency's public health research
program, both for intramural and extramural research activities; (3)
upholds scientific ideals, establishes an environment thriving with
scientific excellence, innovation, integrity, learning and discovery,
and timely dissemination and translation into practice of scientific
information, innovations, and technology with the ultimate goal of
improving public health; (4) facilitates developing strategic and
trans-disciplinary approaches for long-term planning and evaluation of
CDC's scientific enterprise and ensuring sustainability of CDC's
scientific output, establishing and sustaining high-level national and
global alliances and synergy, and a coordinated approach to providing
scientific foundation for development of public health policies; (5)
advises the CDC Director and Senior Staff on science matters and
represents CDC in these areas to the Department, other agencies, and
Congress; (6) develops and disseminates scientific policies for CDC/
ATSDR; (7) maintains the integrity and productivity of CDC's scientists
by resolving controversial scientific issues, supporting trailing and
information exchange, and providing direction on matters of scientific
integrity; (8) assures the protection of human subjects in public
health research and participates in national and international
initiatives in public health protection; (9) manages CDC's intellectual
property (e.g., patents, trademarks, copyrights) and promotes the
transfer of new technology from CDC research to the private sector to
facilitate and enhance the development of diagnostic products,
vaccines, and products to improve occupational safety; (10) manages the
confidentiality function for sensitive research data; (11) facilitates
the agency response to the Privacy Act, the Paperwork Reduction Act,
HIPAA, and FERPA.
Revise the functional statement for the Management Analysis and
Services Office (CAJ6), Office of the Chief Operating Officer (CAJ), by
deleting item (1) and inserting the following: (1) Plans, coordinates,
and provides CDC-wide management and information services in the
following areas: policy development and consultation, studies and
surveys, delegations of authorities, organizations and functions,
records management, printing procurement and reproduction, and meeting
management, forms design and management, publications distribution,
mail services, public inquiries, information quality, and Federal
advisory committee management.
Delete the items (7) and (8) of the functional statement for the
Management Analysis and Policy Branch (CAJ64) and renumber the
remaining items accordingly.
Dated: April 28, 2005.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 05-9539 Filed 5-12-05; 8:45 am]
BILLING CODE 4160-18-M
